Introduction: Psychedelic-assisted psychotherapy is a promising approach in psychiatry;
evidence is growing and it may not be long before mainstream services are expected to offer …

Objective To explore the knowledge and attitudes of psychiatrists about psychedelics
therapies. Method Access to a cross-sectional survey was distributed to psychiatrists through …

Despite resurgent interest in psychedelic-assisted therapy, our insights into psychiatrists'
knowledge and opinions about medicinal psychedelic applications are surprisingly narrow …

Introduction This study explored the current knowledge, attitudes, and clinical practices
regarding psychedelics among mental health professionals in California, where state …

Background Psychedelic compounds such as lysergic acid diethylamide (LSD), psilocybin,
and 3, 4-Methylenedioxymethamphetamine (MDMA) share a long and complex history with …

In recent years, psychedelic-assisted psychotherapies have reentered the realm of rigorous
scientific inquiry, garnering much attention from both the psychiatric community and the …

Objective To assess Australian psychiatrists' and psychiatry trainees' knowledge of and
attitudes towards psychedelics as treatment for psychiatric disorders. Method Australian …

Background and aims Because psychedelic-assisted therapy (PAT) is likely to be provided
by interdisciplinary professional teams comprised of social workers, psychologists, and …

Psychologists are a vital component of mental health treatment and their perceptions of
psychedelic-assisted therapy are critical for future implementation. This cross-sectional …

Modern clinical research on psychedelics is generating interesting outcomes in a wide array
of clinical conditions when psychedelic-assisted psychotherapy is delivered to appropriately …